Company intelligence / Profile preview

PHLECS

Eindhoven, North Brabant, Netherlands

Ownership: Private
Employees: ~10
Development stage: Other

Overview

PHLECS specializes in the development of dermatological medical devices using blue light therapy. Their flagship product, the PHLECS Blue Care, is a CE-marked medical device used for treating chronic inflammatory skin diseases such as psoriasis and atopic dermatitis without the use of UV radiation or chemicals. Clinical studies have shown significant reduction in PASI scores and itch intensity.

Therapeutic areas: Dermatology
Modalities: DeviceNon-pharmacological therapy
Industry: Therapeutic Medical Devices

Partnerships

Leiden University Medical CenterPhilips

Beyond the preview

Go deeper on PHLECS.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PHLECS.

Explore the full profile